All practice questions

4736 questions

All types4,736 Multiple choice2,413 Multiple select567 Numeric127 Matching858 Ordering771

A 34-year-old woman is brought to the emergency department by her husband due to a 3-day history of progressive confusion, severe headache, and profound fatigue. She has also had a subjective fever. The patient has no significant past medical history and takes no medications. Her temperature is $38.2^\circ\text{C}$ ( $100.8^\circ\text{F}$ ), blood pressure is $145/88\text{ mmHg}$ , heart rate is $105/\text{min}$ , and respiratory rate is $18/\text{min}$ . On physical examination, she appears lethargic but is oriented to person and place. Scleral icterus and mucosal pallor are present. There are scattered petechiae over her lower extremities. Neurological examination reveals no focal deficits, but her attention span is significantly impaired.

Laboratory evaluation shows the following:

Test	Result	Reference Range
Hemoglobin	$7.8\text{ g/dL}$	$12.0-15.5\text{ g/dL}$
Platelet count	$18,000/\text{mm}^3$	$150,000-400,000/\text{mm}^3$
Leukocyte count	$8,200/\text{mm}^3$	$4,500-11,000/\text{mm}^3$
Prothrombin time (PT)	$12\text{ sec}$	$11-15\text{ sec}$
Activated PTT	$28\text{ sec}$	$25-40\text{ sec}$
Fibrinogen	$320\text{ mg/dL}$	$150-400\text{ mg/dL}$
Creatinine	$1.9\text{ mg/dL}$	$0.6-1.1\text{ mg/dL}$
Total bilirubin	$3.2\text{ mg/dL}$	$0.1-1.2\text{ mg/dL}$
Indirect bilirubin	$2.8\text{ mg/dL}$	$0.1-0.8\text{ mg/dL}$
Lactate dehydrogenase (LDH)	$1,150\text{ U/L}$	$100-250\text{ U/L}$
Haptoglobin	$< 10\text{ mg/dL}$	$41-165\text{ mg/dL}$

Peripheral blood smear reveals numerous fragmented red blood cells (schistocytes) and absent platelets.

Based on the laboratory and clinical findings, which of the following is the most likely diagnosis?

Thrombotic thrombocytopenic purpura

Disseminated intravascular coagulation

Immune thrombocytopenic purpura

Evans syndrome

Severe vitamin B12 deficiency

Show answer & explanation

Answer: Thrombotic thrombocytopenic purpura

Answer

Thrombotic thrombocytopenic purpura

The correct answer is thrombotic thrombocytopenic purpura (TTP). This patient's laboratory results demonstrate microangiopathic hemolytic anemia (MAHA) and severe thrombocytopenia. The presence of schistocytes, elevated indirect bilirubin, high LDH, and low haptoglobin confirms intravascular hemolysis. Crucially, the normal PT, aPTT, and fibrinogen levels distinguish TTP from disseminated intravascular coagulation (DIC). The classic clinical pentad of TTP includes MAHA, thrombocytopenia, neurological abnormalities, fever, and renal insufficiency, all of which are present or evolving in this patient.

Step-by-Step Solution

Analyze the complete blood count and hemolysis markers.

The patient has severe thrombocytopenia and microangiopathic hemolytic anemia (MAHA), evidenced by low hemoglobin, schistocytes, elevated LDH, elevated indirect bilirubin, and low haptoglobin.

Identifying the type of anemia and the presence of concurrent cytopenias narrows the initial differential diagnosis.

Evaluate the coagulation panel.

Prothrombin time (PT), activated partial thromboplastin time (aPTT), and fibrinogen are all within normal limits.

In patients presenting with MAHA and thrombocytopenia, evaluating coagulation studies is critical to exclude disseminated intravascular coagulation (DIC).

Synthesize laboratory findings with the clinical presentation.

The combination of MAHA, severe thrombocytopenia, normal coagulation studies, fever, and acute neurologic changes (confusion) classically defines thrombotic thrombocytopenic purpura (TTP).

TTP is a medical emergency that requires prompt clinical recognition based on this specific constellation of laboratory and clinical findings.

Key Concept

Differentiating microangiopathic hemolytic anemias based on coagulation studies (TTP vs. DIC)

Estimated Time:1m 30s

Question 4182Question →

A medical resident is evaluating four adult patients admitted to the inpatient ward with overlapping signs of pulmonary dysfunction, renal impairment, and systemic illness. Match each patient's specific clinical and diagnostic presentation with the most accurate differential diagnosis.

Click a left item, then click its matching right item

Show answer & explanation

Answer

The patients represent distinct manifestations of pulmonary-renal syndromes and small-vessel vasculitides: the asthmatic patient with eosinophilia has Eosinophilic granulomatosis with polyangiitis; the patient with upper airway necrosis and granulomas has Granulomatosis with polyangiitis; the patient lacking upper airway disease and granulomas has Microscopic polyangiitis; and the patient with linear IgG deposition has Anti-glomerular basement membrane disease.

Correctly formulating this differential diagnosis relies on recognizing key discriminators. Asthma and mononeuritis multiplex with eosinophilia point directly to Eosinophilic granulomatosis with polyangiitis. The presence of destructive upper airway disease and necrotizing granulomas defines Granulomatosis with polyangiitis. The absence of these features in a patient with a similar pulmonary-renal pattern suggests Microscopic polyangiitis. Finally, linear IgG immunofluorescence is the pathognomonic signature of Anti-glomerular basement membrane disease.

Step-by-Step Solution

Analyze each patient's clinical history for unique phenotypic markers of small-vessel vasculitis.

Patient 1 has asthma and eosinophilia. Patient 2 has severe upper respiratory tract destruction. Patient 3 lacks upper airway symptoms. Patient 4 is young, a smoker, and has isolated pulmonary-renal symptoms.

Phenotypic clinical features (like asthma or saddle-nose deformity) rapidly narrow the differential diagnosis among systemic vasculitides.

Evaluate the tissue biopsy results for distinguishing pathophysiological characteristics.

Patient 2 has granulomas. Patient 3 has capillaritis without granulomas. Patient 4 has linear IgG deposition.

Histopathology definitively separates pauci-immune vasculitides (which either have or lack granulomas) from immune-complex or anti-GBM mediated disease.

Synthesize the clinical and histologic data to formulate the final diagnosis for each patient.

Matches are made based on the pathognomonic combinations of clinical phenotype and biopsy results.

Establishing a precise diagnosis is required to guide specific immunosuppressive therapy and determine prognosis.

Key Concept

Formulating a differential diagnosis for pulmonary-renal syndromes by integrating clinical phenotypes (asthma, upper airway disease) with distinct biopsy findings (granulomas, linear immunofluorescence).

Question 4183Question →

A 31-year-old woman is rushed to the emergency department triage desk by her colleagues. They report she suddenly developed severe throat tightness, shortness of breath, and dizziness approximately ten minutes after consuming a pastry at a local café. The patient has a past medical history of poorly controlled asthma and a severe peanut allergy. On arrival, she is visibly lethargic, diaphoretic, and grasping at her neck. Her vital signs are temperature 36.9°C (98.4°F), heart rate 148/min, blood pressure 72/42 mm Hg, respiratory rate 34/min, and oxygen saturation 84% on room air. Physical examination reveals audible inspiratory stridor, widespread erythematous urticaria, and perioral cyanosis. Her level of consciousness continues to rapidly decline while in the resuscitation bay. Which of the following are the most appropriate immediate steps in the management of this patient? (Select all that apply)

Select all that apply

Intramuscular injection of epinephrine in the anterolateral thigh

Preparation and execution of rapid sequence endotracheal intubation

Intravenous administration of methylprednisolone and diphenhydramine

Acquisition of a stat portable chest radiograph to evaluate for mechanical obstruction

Immediate transport to the intensive care unit for specialized airway monitoring

Show answer & explanation

Answer: Intramuscular injection of epinephrine in the anterolateral thigh; Preparation and execution of rapid sequence endotracheal intubation

Answer

The correct immediate steps are the intramuscular injection of epinephrine in the anterolateral thigh and the preparation and execution of rapid sequence endotracheal intubation.

The correct answers directly address the primary life threats in this patient. The presentation of audible stridor, perioral cyanosis, and declining mental status indicates an airway that is actively closing, requiring immediate rapid sequence intubation. Concurrently, the profound hypotension and systemic allergic response necessitate intramuscular epinephrine, which is the only pharmacologic agent proven to decrease mortality in anaphylactic shock by rapidly reversing vasodilation and bronchoconstriction.

Step-by-Step Solution

Assess the patient's primary life threats based on the primary survey (ABCs).

The patient has a compromised airway (stridor, cyanosis), inadequate breathing (hypoxia, tachypnea), and circulatory collapse (hypotension, tachycardia) due to anaphylactic shock.

Initial triage and stabilization require immediate identification of conditions that will cause imminent death if not rapidly reversed.

Determine the necessary interventions for airway and breathing.

Rapid sequence endotracheal intubation must be prepared and executed.

Audible stridor and a declining level of consciousness indicate impending total airway occlusion from laryngeal edema, which necessitates a definitive surgical or endotracheal airway.

Determine the necessary interventions for circulatory collapse.

Intramuscular epinephrine must be administered immediately.

Epinephrine is the only medication capable of rapidly reversing the vasodilation, bronchoconstriction, and mast cell degranulation seen in severe anaphylaxis.

Key Concept

In severe anaphylaxis presenting with both impending airway loss and profound shock, simultaneous life-saving interventions (definitive airway management and intramuscular epinephrine) must be prioritized over adjunctive medications, imaging, or patient transport.

Question 4184Question →

A 42-year-old woman presents to the emergency department with a 12-hour history of severe, constant right upper quadrant abdominal pain. The pain radiates to her right scapula and is associated with nausea and two episodes of non-bilious emesis. Her temperature is $38.2^\circ\text{C}$ ( $100.8^\circ\text{F}$ ), blood pressure is $130/80\text{ mmHg}$ , pulse is $98/\text{min}$ , and respiratory rate is $16/\text{min}$ . Physical examination reveals focal tenderness to palpation in the right upper quadrant with inspiratory arrest upon deep palpation. Laboratory studies show a leukocyte count of $13,000/\text{mm}^3$ with $80\%$ neutrophils. Liver function tests, amylase, and lipase are within normal limits. A right upper quadrant abdominal ultrasound is performed, which demonstrates multiple mobile gallstones and a common bile duct measuring $4\text{ mm}$ in diameter. However, there is no gallbladder wall thickening and no pericholecystic fluid visualized.

Which of the following is the most appropriate next imaging study?

Computed tomography (CT) of the abdomen and pelvis with intravenous contrast

Magnetic resonance cholangiopancreatography (MRCP)

Hepatobiliary iminodiacetic acid (HIDA) scan

Endoscopic retrograde cholangiopancreatography (ERCP)

Repeat right upper quadrant abdominal ultrasound in 48 hours

Show answer & explanation

Answer: Hepatobiliary iminodiacetic acid (HIDA) scan

Answer

Hepatobiliary iminodiacetic acid (HIDA) scan

The correct answer is to order a hepatobiliary iminodiacetic acid (HIDA) scan, also known as cholescintigraphy. This patient presents with a classic clinical picture of acute cholecystitis, including right upper quadrant pain, fever, leukocytosis, and a positive Murphy sign. Right upper quadrant ultrasound is the standard initial imaging modality. While the ultrasound confirmed the presence of gallstones, it did not show definitive signs of acute inflammation (e.g., gallbladder wall thickening >4 mm, pericholecystic fluid). When the clinical suspicion is high but the initial ultrasound is equivocal, a HIDA scan is the most sensitive and specific next step. In a positive HIDA scan, the radiotracer enters the liver and common bile duct but fails to enter the gallbladder due to cystic duct obstruction, which is the pathophysiologic hallmark of acute cholecystitis.

Step-by-Step Solution

Analyze the clinical presentation

The patient has signs and symptoms highly suspicious for acute cholecystitis (fever, leukocytosis, right upper quadrant pain, positive Murphy sign).

Establishing the pre-test probability is crucial before selecting diagnostic imaging.

Evaluate the initial imaging results

Right upper quadrant ultrasound shows gallstones but lacks definitive findings of acute cholecystitis (no wall thickening, no pericholecystic fluid).

Ultrasound is the best initial test, but its sensitivity can vary; lack of secondary signs makes it equivocal.

Select the appropriate follow-up test

A cholescintigraphy (HIDA) scan is selected to definitively confirm or rule out acute cholecystitis.

HIDA scan evaluates gallbladder function and cystic duct patency; non-visualization of the gallbladder confirms the diagnosis.

Key Concept

When a patient has a clinical presentation highly suspicious for acute cholecystitis but the initial right upper quadrant ultrasound is equivocal, cholescintigraphy (HIDA scan) is the most appropriate next diagnostic step.

Question 4185Question →

A $48$ -year-old woman comes to the clinic reporting a $6$ -month history of severe, generalized pruritus that is worse at night. She also reports worsening fatigue during this period but denies abdominal pain, weight changes, dark urine, or changes in bowel habits. Her medical history is unremarkable, and she takes no medications. She consumes alcohol on rare social occasions and has no history of illicit drug use. Vital signs are within normal limits. Physical examination demonstrates extensive excoriations over her arms and legs. There is no scleral icterus, spider angiomata, or palmar erythema. The abdomen is soft and non-tender, with no palpable hepatosplenomegaly.

Laboratory results are as follows:
Total bilirubin: $1.0$ mg/dL
Aspartate aminotransferase (AST): $42$ U/L
Alanine aminotransferase (ALT): $46$ U/L
Alkaline phosphatase: $610$ U/L
Gamma-glutamyl transferase (GGT): $420$ U/L

Which of the following is the most appropriate next step in the diagnostic workup?

Right upper quadrant abdominal ultrasonography

Assay for serum antimitochondrial antibodies

Magnetic resonance cholangiopancreatography

Endoscopic retrograde cholangiopancreatography

Percutaneous liver biopsy

Show answer & explanation

Answer: Right upper quadrant abdominal ultrasonography

Answer

Right upper quadrant abdominal ultrasonography

The correct answer is right upper quadrant abdominal ultrasonography. This patient has a classic cholestatic pattern of liver injury, characterized by a markedly elevated alkaline phosphatase out of proportion to the aminotransferases. The concurrent elevation of gamma-glutamyl transferase (GGT) confirms that the alkaline phosphatase is of hepatic (rather than bone) origin. The absolute first step in evaluating any confirmed hepatic cholestatic injury is to differentiate between extrahepatic biliary obstruction (e.g., gallstones, strictures, or tumors) and intrahepatic cholestasis (e.g., primary biliary cholangitis, primary sclerosing cholangitis, drug-induced liver injury). Right upper quadrant ultrasonography is the most appropriate initial, non-invasive, and cost-effective test to assess for biliary ductal dilation, which is the hallmark of extrahepatic obstruction.

Step-by-Step Solution

Analyze the laboratory data to identify the predominant pattern of liver injury.

The patient has a markedly elevated alkaline phosphatase with normal bilirubin and near-normal transaminases. The concurrently elevated GGT confirms that the alkaline phosphatase is of hepatic origin, establishing a cholestatic pattern.

Differentiating hepatocellular injury (high AST/ALT) from cholestatic injury (high Alk Phos/GGT) dictates the entirely different subsequent diagnostic pathways.

Determine the first crucial branching point in the workup of cholestatic liver injury.

The initial step must distinguish between extrahepatic biliary obstruction (e.g., stones, masses) and intrahepatic cholestasis (e.g., primary biliary cholangitis).

Anatomic obstruction requires entirely different management (often surgical or endoscopic) compared to intrahepatic medical conditions.

Select the most appropriate initial modality to evaluate for biliary ductal dilation.

Right upper quadrant abdominal ultrasonography is selected.

Ultrasonography is non-invasive, cost-effective, and highly sensitive for detecting biliary ductal dilation, making it the guideline-directed first diagnostic test.

Key Concept

The initial diagnostic step for any confirmed hepatic cholestatic pattern (elevated alkaline phosphatase and GGT) is abdominal ultrasonography to evaluate for extrahepatic biliary ductal dilation, prior to checking specific intrahepatic serologies.

Estimated Time:1m 15s

Question 4186Question →

A primary care physician is evaluating a 29-year-old nulliparous woman who presents with acute unilateral leg swelling and discomfort. Venous duplex ultrasonography confirms a deep vein thrombosis in the left popliteal vein. Her past medical history is significant for three consecutive spontaneous first-trimester pregnancy losses. She takes no medications. Initial coagulation laboratory analysis shows a normal prothrombin time (PT) but an activated partial thromboplastin time (aPTT) of 62 seconds (reference range: 25-35 seconds). To further evaluate the isolated aPTT prolongation, a 1:1 mixing study with normal pooled plasma is performed, which yields a repeat aPTT of 58 seconds. Based on these laboratory results, which of the following is the most likely underlying etiology?

Presence of a circulating inhibitor directed against phospholipid-protein complexes

Congenital deficiency of coagulation factor VIII

Genetic mutation causing resistance to cleavage by activated protein C

Acquired depletion of vitamin K-dependent clotting factors

Decreased production of a carrier protein for factor VIII

Show answer & explanation

Answer: Presence of a circulating inhibitor directed against phospholipid-protein complexes

Answer

Presence of a circulating inhibitor directed against phospholipid-protein complexes

The correct answer identifies a circulating inhibitor against phospholipid-protein complexes, known clinically as the lupus anticoagulant. This patient's presentation of unprovoked deep vein thrombosis and a history of recurrent first-trimester pregnancy losses is highly specific for antiphospholipid syndrome (APS). The laboratory hallmark of the lupus anticoagulant is an isolated prolongation of the aPTT. Crucially, because it is an inhibitor (an antibody targeting the phospholipids used in the assay) rather than a deficiency of a clotting factor, the addition of normal pooled plasma during a 1:1 mixing study fails to correct the aPTT into the normal range.

Step-by-Step Solution

Interpret the clinical presentation

The patient has unprovoked venous thrombosis and recurrent spontaneous abortions.

This specific combination of clinical findings is the classic presentation for antiphospholipid syndrome (APS).

Analyze the initial coagulation panel

Isolated prolongation of the aPTT with a normal PT.

An isolated prolonged aPTT indicates an issue in the intrinsic pathway (Factors VIII, IX, XI, XII) or the presence of an inhibitor.

Interpret the 1:1 mixing study results

The aPTT fails to correct to the normal reference range after mixing with normal pooled plasma.

Failure to correct indicates the presence of a circulating inhibitor (such as the lupus anticoagulant) rather than a simple factor deficiency.

Synthesize lab and clinical data to establish the etiology

The lupus anticoagulant is an antiphospholipid antibody that binds phospholipid-protein complexes, causing artifactual in vitro aPTT prolongation but paradoxically promoting in vivo thrombosis.

This pathophysiology perfectly explains both the patient's hypercoagulable clinical state and her specific laboratory pattern.

Key Concept

The lupus anticoagulant causes an isolated, prolonged aPTT that does not correct with a 1:1 mixing study. Paradoxically, it manifests clinically with a prothrombotic state (Antiphospholipid Syndrome).

Question 4187Question →

A 42-year-old woman with systemic lupus erythematosus on chronic glucocorticoid therapy presents with progressive right groin pain exacerbated by weight-bearing. She is diagnosed with osteonecrosis (avascular necrosis) of the femoral head. Staging and subsequent treatment (e.g., core decompression versus total hip arthroplasty) rely heavily on the interpretation of specific radiologic features over time. Arrange the following imaging findings in chronological order, representing the natural progression of untreated osteonecrosis from the earliest pathologic stage to the most advanced, terminal stage.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence is: normal radiographs with MRI edema (Stage I), followed by radiographic sclerotic/cystic changes with preserved contour (Stage II), then the subchondral 'crescent sign' (Stage III), and finally femoral head flattening with joint space narrowing (Stage IV).

The natural history of osteonecrosis begins with ischemic cell death that is initially undetectable on plain X-rays but identifiable on MRI as marrow edema. As the surrounding living bone attempts to remodel the necrotic zone, mixed sclerosis and cysts appear on X-rays. With continued mechanical stress on weakened necrotic bone, a subchondral microfracture occurs (the crescent sign). Ultimately, the structural integrity of the femoral head fails, causing flattening, collapse, and secondary degenerative joint disease.

Step-by-Step Solution

Identify the earliest pathologic changes of osteonecrosis on imaging.

Normal plain radiography with bone marrow edema visible only on MRI (Item 1).

Before structural bone remodeling occurs, ischemic death of bone cells causes edema that is uniquely detectable by MRI.

Determine the initial radiographic changes prior to structural failure.

Mixed osteosclerotic and radiolucent (cystic) changes on plain radiography (Item 2).

The body attempts to repair the necrotic area via creeping substitution, leading to areas of resorption (cysts) and new bone formation (sclerosis) without altering the femoral head contour.

Identify the imaging sign of initial mechanical failure.

Presence of a subchondral radiolucent line or 'crescent sign' (Item 3).

As the necrotic bone weakens, microfractures occur beneath the articular cartilage, visible on X-ray as the crescent sign, heralding impending collapse.

Recognize the terminal imaging findings of untreated disease.

Flattening and collapse of the femoral head with secondary osteoarthritic changes (Item 4).

Loss of structural integrity results in flattening of the femoral head, which subsequently damages the acetabulum and leads to joint space narrowing and advanced osteoarthritis.

Key Concept

The progression of imaging findings in avascular necrosis of the femoral head follows a predictable sequence: pre-radiographic MRI changes (Stage I), radiographic remodeling without collapse (Stage II), subchondral fracture indicated by the crescent sign (Stage III), and structural collapse with secondary osteoarthritis (Stage IV).

Question 4188Question →

An $81$ -year-old woman is brought to the emergency department from an assisted living facility due to the passage of $3$ large, dark maroon bowel movements mixed with clots over the past two hours. Her medical history includes hypertension, osteoarthritis, and permanent atrial fibrillation, for which she takes apixaban, lisinopril, and as-needed acetaminophen. On arrival, her temperature is $36.8^{\circ}\text{C}$ ( $98.2^{\circ}\text{F}$ ), blood pressure is $82/50$ mm Hg, pulse is $118$ /min, and respirations are $18$ /min. Physical examination reveals a pale, lethargic patient. Her abdomen is soft and non-tender without guarding. Digital rectal examination demonstrates gross maroon blood. Intravenous access is rapidly established. Initial laboratory studies show a hemoglobin level of $7.2$ g/dL (baseline $11.5$ g/dL six months ago).

Arrange the following procedural and management steps in the most appropriate chronological order for evaluating and treating this patient's condition.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence of management for severe, hemodynamically unstable lower gastrointestinal bleeding in a patient on anticoagulation is initial volume resuscitation and medication reversal, followed by an esophagogastroduodenoscopy to rule out a massive upper gastrointestinal source, followed by a computed tomography angiography to anatomically localize the bleeding, and finally conventional mesenteric angiography for therapeutic embolization.

Evidence-based guidelines mandate a strict sequence for managing suspected severe lower gastrointestinal bleeding (LGIB) with hemodynamic instability. First, the patient must be resuscitated (fluids, blood products, and reversal of anticoagulants). Second, an upper GI source must be ruled out with an EGD, as approximately

10\%

15\%

of massive hematochezia cases originate proximal to the ligament of Treitz. Third, once an upper source is excluded, CTA is the preferred first-line imaging modality to localize the bleed because it is rapid, non-invasive, and highly sensitive. Finally, conventional mesenteric angiography is performed using the CTA roadmap for targeted therapeutic embolization.

Step-by-Step Solution

Recognize hemorrhagic shock and prioritize immediate hemodynamic stabilization.

Initiate aggressive intravenous fluid resuscitation, transfuse packed red blood cells, and administer a reversal agent for apixaban (e.g., andexanet alfa or prothrombin complex concentrate).

Diagnostic procedures cannot be safely performed or interpreted in a patient who is actively exsanguinating and profoundly hypotensive without concurrent volume replacement and coagulopathy correction.

Evaluate for a massive upper gastrointestinal source of bleeding.

Perform an urgent esophagogastroduodenoscopy (EGD).

Brisk bleeding from the upper GI tract (e.g., bleeding peptic ulcer or varices) frequently presents with hematochezia and hemodynamic instability. Intervening in the lower GI tract first would miss a potentially fatal, yet endoscopically treatable, upper GI hemorrhage.

Localize the lower gastrointestinal bleeding source non-invasively.

Perform a computed tomography angiography (CTA) of the abdomen and pelvis.

CTA can rapidly identify active bleeding rates as low as

0.3

mL/min. It provides a precise anatomic roadmap, which significantly increases the technical success rate and decreases the complication rate of subsequent interventions.

Perform definitive therapeutic intervention based on imaging findings.

Perform catheter-directed mesenteric angiography and embolization.

Using the roadmap provided by the CTA, the interventional radiologist can selectively catheterize and embolize the actively bleeding vessel, successfully stopping the hemorrhage while minimizing ischemic damage to the bowel.

Key Concept

Algorithmic procedural sequencing for massive, hemodynamically unstable lower gastrointestinal bleeding.

Question 4189Question →

A 35-year-old woman presents to the clinic with a one-month history of progressive muscle weakness and fatigue. She also reports a gritty sensation in her eyes and feeling the need to drink water frequently to comfortably swallow dry foods. Vital signs are within normal limits. Physical examination is notable for dry oral mucosa and 4/5 muscle strength in the proximal lower extremities.

Laboratory results are as follows:

Serum chemistry

Analyte	Value	Reference Range
Sodium	139 mEq/L	136-145 mEq/L
Potassium	2.5 mEq/L	3.5-5.0 mEq/L
Chloride	114 mEq/L	98-106 mEq/L
Bicarbonate	15 mEq/L	22-28 mEq/L
Blood urea nitrogen	12 mg/dL	7-18 mg/dL
Creatinine	0.8 mg/dL	0.6-1.2 mg/dL

Arterial blood gas (room air)

Parameter	Value	Reference Range
pH	7.28	7.35-7.45
pCO2	30 mm Hg	35-45 mm Hg
pO2	95 mm Hg	75-105 mm Hg

Urine studies

Parameter	Value	Reference Range
pH	6.5	4.5-8.0
Sodium	65 mEq/L	Variable
Potassium	35 mEq/L	Variable
Chloride	40 mEq/L	Variable

Based on the provided laboratory data, which of the following is the most likely underlying mechanism for this patient's electrolyte and acid-base disturbances?

Impaired hydrogen ion secretion in the distal tubule

Defective bicarbonate reabsorption in the proximal tubule

Aldosterone resistance at the cortical collecting duct

Extrarenal bicarbonate loss with appropriate renal compensation

Renal chloride loss with secondary hyperaldosteronism

Show answer & explanation

Answer: Impaired hydrogen ion secretion in the distal tubule

Answer

Impaired hydrogen ion secretion in the distal tubule

This patient is presenting with a normal anion gap metabolic acidosis, indicated by a serum anion gap of

10 \text{ mEq/L}

(

139 - 114 - 15 = 10

). To differentiate between extrarenal bicarbonate loss (e.g., diarrhea) and impaired renal acid excretion (renal tubular acidosis), the urine anion gap (UAG) should be calculated. The UAG in this patient is

+60 \text{ mEq/L}

(

65 + 35 - 40 = 60

). A positive UAG indicates that the kidneys are not excreting sufficient ammonium (

NH_4^+

), confirming a renal etiology. Among the RTAs, the presence of hypokalemia points to either Type 1 or Type 2, while the inappropriately elevated urine pH (6.5) despite severe systemic acidemia is the hallmark of Type 1 (distal) RTA. Type 1 RTA is characterized by impaired hydrogen ion secretion in the alpha-intercalated cells of the distal tubule and is frequently associated with autoimmune disorders, such as Sjögren syndrome (strongly suggested by this patient's dry eyes and dry mouth).

Step-by-Step Solution

Calculate the serum anion gap to classify the primary acid-base disturbance.

Serum Anion Gap =

Na^+ - (Cl^- + HCO_3^-) = 139 - (114 + 15) = 10 \text{ mEq/L}

. The patient has a normal anion gap metabolic acidosis (NAGMA).

Categorizing the metabolic acidosis narrows the differential diagnosis to renal tubular acidoses (RTAs) or gastrointestinal bicarbonate losses.

Calculate the urine anion gap (UAG) to distinguish renal from extrarenal causes of NAGMA.

UAG =

U_{Na} + U_{K} - U_{Cl} = 65 + 35 - 40 = +60 \text{ mEq/L}

. A positive UAG indicates impaired renal ammonium (

NH_4^+

) excretion.

A negative UAG suggests appropriate renal acidification (extrarenal bicarbonate loss), whereas a positive UAG points to a renal tubular acidification defect (RTA).

Evaluate the urine pH, serum potassium, and clinical context to specify the type of RTA.

The patient has hypokalemia and a urine pH of 6.5 (inappropriately alkaline in the face of systemic acidosis). Combined with sicca symptoms (suggestive of Sjögren syndrome), this confirms Type 1 RTA.

Type 1 RTA is characterized by an inability to secrete

H^+

in the distal tubule, leading to high urine pH (> 5.5) and hypokalemia.

Key Concept

Normal anion gap metabolic acidosis with a positive urine anion gap, hypokalemia, and urine pH > 5.5 is diagnostic of Type 1 (distal) renal tubular acidosis, which is commonly associated with autoimmune conditions like Sjögren syndrome.

Question 4190Question →

Match each of the following cerebrospinal fluid (CSF) laboratory profiles obtained via lumbar puncture to its most likely clinical diagnosis. Assume a normal serum glucose level of 90-100 mg/dL for all patients.

Click a left item, then click its matching right item

Show answer & explanation

Answer

Profile 1 matches Bacterial Meningitis. Profile 2 matches Viral Meningitis. Profile 3 matches Tuberculous Meningitis. Profile 4 matches Guillain-Barré Syndrome. Profile 5 matches Subarachnoid Hemorrhage.

Each CSF laboratory profile reflects the specific pathophysiology of the matching condition. Bacterial infections consume glucose and recruit neutrophils. Viral infections trigger a lymphocytic response without consuming glucose. TB/Fungal infections trigger a lymphocytic response but consume glucose and raise protein significantly. Immune-mediated root damage in GBS leaks protein into the CSF without white cells. A ruptured aneurysm leaks RBCs directly into the subarachnoid space, which break down into bilirubin, causing xanthochromia.

Step-by-Step Solution

Analyze the cell differentials for each profile.

Profile 1 has neutrophils, Profiles 2 and 3 have lymphocytes, Profile 4 has no significant cells, and Profile 5 has RBCs.

The predominant cell type narrows down the etiology to bacterial (neutrophils), viral/fungal/TB (lymphocytes), demyelinating (acellular), or hemorrhagic (RBCs).

Evaluate the glucose levels in the infectious profiles (Profiles 1, 2, and 3).

Profiles 1 and 3 have abnormally low glucose (<40 mg/dL), while Profile 2 has a normal glucose.

Low glucose strongly points to bacterial, TB, or fungal causes, effectively ruling out a viral etiology for Profiles 1 and 3.

Assess the protein levels across all non-infectious looking profiles.

Profile 4 shows isolated elevated protein without an increase in white blood cells.

This albuminocytologic dissociation is the diagnostic hallmark for Guillain-Barré Syndrome.

Differentiate between a traumatic tap and true hemorrhage for Profile 5.

Profile 5 shows consistent RBCs across multiple tubes and xanthochromia.

Xanthochromia (yellow discoloration from bilirubin) and un-clearing RBCs confirm a true Subarachnoid Hemorrhage rather than bleeding caused by the needle insertion.

Key Concept

Interpreting Cerebrospinal Fluid (CSF) Laboratory Profiles

Question 4191Question →

An adult female patient is evaluated in the outpatient clinic for a recent history of progressive weight gain, easy bruising, and proximal muscle weakness. Physical examination reveals facial plethora, supraclavicular fat pads, and violaceous striae on the lower abdomen. Her blood pressure is 154/96 mm Hg. The physician strongly suspects endogenous hypercortisolism (Cushing syndrome) and plans a stepwise evaluation to confirm the diagnosis and localize the etiology. Arrange the following diagnostic steps in the most appropriate sequential order, from initial screening to final invasive localization.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: Measurement of 24-hour urine free cortisol -> Measurement of plasma adrenocorticotropic hormone (ACTH) level -> High-dose dexamethasone suppression test -> Magnetic resonance imaging (MRI) of the pituitary gland -> Bilateral inferior petrosal sinus sampling.

The diagnostic pathway for Cushing syndrome must follow a strict logical sequence to prevent misdiagnosis. First, endogenous hypercortisolism must be confirmed (e.g., via 24-hour urine free cortisol). Once confirmed, a plasma ACTH level determines if the condition is ACTH-dependent or ACTH-independent. For ACTH-dependent cases, a high-dose dexamethasone suppression test helps differentiate a pituitary source from an ectopic source. Only after this biochemical evidence points to the pituitary gland should an MRI be performed. Finally, if the MRI is negative or reveals a lesion smaller than 6 mm, bilateral inferior petrosal sinus sampling is indicated to definitively confirm the presence of an ACTH-secreting pituitary microadenoma before proceeding to surgery.

Step-by-Step Solution

Confirm the presence of hypercortisolism.

Measurement of 24-hour urine free cortisol (or low-dose dexamethasone suppression test / late-night salivary cortisol).

Establishing the diagnosis of Cushing syndrome is the mandatory first step to avoid false positives.

Determine if the hypercortisolism is ACTH-dependent or independent.

Measurement of plasma ACTH level.

This categorizes the etiology into central/ectopic (ACTH-dependent) versus adrenal (ACTH-independent).

Differentiate the source of ACTH-dependent hypercortisolism.

High-dose dexamethasone suppression test.

Pituitary adenomas typically suppress cortisol production with high-dose dexamethasone, whereas ectopic ACTH tumors usually do not.

Anatomically localize the suspected tumor.

Magnetic resonance imaging (MRI) of the pituitary gland.

Biochemical testing must direct imaging to minimize the risk of identifying non-functioning incidentalomas.

Perform invasive confirmatory testing if imaging is inconclusive.

Bilateral inferior petrosal sinus sampling.

If the MRI is negative or shows a lesion smaller than 6 mm, IPSS is required to definitively confirm a pituitary source before neurosurgery.

Key Concept

The diagnostic workup of Cushing syndrome follows a strict tier: confirm hypercortisolism, establish ACTH dependence, differentiate the ACTH source biochemically, localize the lesion anatomically, and pursue invasive sampling only if non-invasive localization is equivocal.

Estimated Time:1m 30s

Question 4192Question →

Match each clinical presentation with the single most appropriate initial diagnostic imaging modality.

Click a left item, then click its matching right item

Show answer & explanation

Answer

The correct matches are: the hematuria patient requires CT urography; the dysphagia patient requires a barium esophagram; the thyroid nodule patient requires an ultrasound; and the back pain patient requires an MRI of the spine.

Each clinical scenario corresponds to a well-established, evidence-based imaging guideline. CT urography is standard for high-risk hematuria evaluation. A barium esophagram safely identifies Zenker diverticula. Ultrasound characterizes thyroid nodules when TSH is not suppressed. MRI sensitively detects spinal metastases in patients with cancer histories.

Step-by-Step Solution

Evaluate the hematuria presentation.

Identify risk factors for malignancy (age, smoking) and select CT urography.

Complete evaluation of painless macroscopic hematuria includes direct visualization of the bladder and cross-sectional imaging of the upper urinary tract.

Evaluate the dysphagia presentation.

Identify classic signs of a Zenker diverticulum and select barium esophagram.

A contrast study safely delineates the anatomical pouch, whereas an initial upper endoscopy poses an unacceptable risk of iatrogenic perforation.

Evaluate the thyroid nodule presentation.

Note the normal TSH level and select high-resolution ultrasound.

A normal TSH indicates the nodule is non-functioning, making ultrasound the standard next step to evaluate for malignant features.

Evaluate the back pain presentation.

Recognize red flag symptoms (history of cancer, nocturnal pain) and select MRI of the spine.

MRI is the most sensitive modality for detecting metastatic disease in the spine and assessing for epidural spinal cord compression.

Key Concept

Evidence-based selection of initial diagnostic imaging based on specific clinical presentations and associated risk factors.

Question 4193Question →

A 34-year-old woman is evaluated in the outpatient clinic for progressive weight gain, generalized weakness, and easy bruising over the past eight months. She notes her face has become "rounder" and she has developed dark hair on her chin. Medical history is notable for newly diagnosed hypertension and type 2 diabetes mellitus, which are poorly controlled despite escalating therapy. She does not take any prescription, over-the-counter, or herbal medications, and specifically denies using exogenous corticosteroids. On physical examination, blood pressure is 158/96 mmHg and heart rate is 82/min. She has facial plethora, a prominent dorsocervical fat pad, central adiposity with thin extremities, and wide violaceous striae on her abdomen. Proximal muscle weakness is noted in the lower extremities.

Arrange the following diagnostic investigations in the correct sequential order for the comprehensive evaluation of this patient's condition, starting from the initial diagnostic screening to the final localization procedure.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct diagnostic sequence is: 1) 24-hour urine free cortisol or late-night salivary cortisol, 2) morning plasma ACTH concentration, 3) MRI of the pituitary gland, and 4) Bilateral inferior petrosal sinus sampling (BIPSS).

The diagnostic workup for Cushing syndrome in an outpatient elective setting must follow a strict sequential algorithm to prevent premature closure and unnecessary invasive testing. The sequence begins by proving endogenous hypercortisolism exists using first-line screening tests (e.g., 24-hour urine free cortisol or late-night salivary cortisol). Once hypercortisolism is established, a plasma ACTH level must be obtained to classify the etiology as ACTH-dependent (pituitary or ectopic) or ACTH-independent (primary adrenal). Only if the disease is proven to be ACTH-dependent should anatomical imaging (pituitary MRI) be ordered. Finally, if the MRI does not clearly demonstrate a pituitary adenoma larger than 6 mm, Bilateral inferior petrosal sinus sampling (BIPSS) is required to definitively distinguish a tiny pituitary adenoma from an occult ectopic ACTH-producing neuroendocrine tumor.

Step-by-Step Solution

Confirm the presence of pathological hypercortisolism.

Perform initial screening using 24-hour urine free cortisol, late-night salivary cortisol, or a 1-mg overnight dexamethasone suppression test.

Because clinical signs overlap with common conditions like simple obesity and PCOS, autonomous hypercortisolism must be biochemically proven before any further workup.

Determine if the hypercortisolism is ACTH-dependent or ACTH-independent.

Measure morning plasma ACTH concentration.

A suppressed ACTH indicates an adrenal source (ACTH-independent), whereas a normal or elevated ACTH indicates a pituitary or ectopic source (ACTH-dependent).

Anatomically localize the source of ACTH production.

Perform an MRI of the pituitary gland.

If the disease is ACTH-dependent, a pituitary adenoma (Cushing disease) is the most common cause. Dedicated pituitary MRI evaluates for a visible adenoma.

Differentiate pituitary from ectopic ACTH secretion if imaging is non-diagnostic.

Perform Bilateral inferior petrosal sinus sampling (BIPSS).

Because pituitary incidentalomas are common, BIPSS is required to definitively prove the pituitary is the source of excess ACTH if the MRI is normal or shows an adenoma smaller than 6 mm.

Key Concept

Diagnostic sequencing for Cushing syndrome progresses strictly from biochemical confirmation of hypercortisolism (screening tests), to determining ACTH dependence (plasma ACTH), to anatomical localization (MRI), and finally to invasive sampling (BIPSS) if imaging is indeterminate.

Question 4194Question →

A 32-year-old woman comes to the clinic for evaluation of chronic diarrhea and unintentional weight loss over the past eight months. She describes having 3 to 4 loose, foul-smelling bowel movements daily, accompanied by abdominal bloating. She also reports significant fatigue. Her medical history is unremarkable, and she takes no medications. Vital signs are within normal limits. Physical examination reveals mild diffuse abdominal tenderness without guarding or rebound. Laboratory studies obtained last week show a hemoglobin of 10.5 g/dL with a mean corpuscular volume of 74 fL. Which of the following is the most appropriate next step in laboratory evaluation?

Tissue transglutaminase IgA antibody and total serum IgA levels

IgG antibodies against deamidated gliadin peptides

Human leukocyte antigen (HLA) DQ2 and DQ8 typing

Fecal calprotectin level

Comprehensive stool microbiology panel including culture

Show answer & explanation

Answer: Tissue transglutaminase IgA antibody and total serum IgA levels

Answer

Tissue transglutaminase IgA antibody and total serum IgA levels

The correct answer involves ordering tissue transglutaminase IgA antibody and total serum IgA levels. This patient presents with classic signs of malabsorption, including chronic diarrhea, bloating, weight loss, and iron deficiency anemia (microcytic anemia). Celiac disease is highly suspected. The most sensitive and specific initial diagnostic laboratory test for celiac disease is the IgA anti-tissue transglutaminase (tTG) antibody. Because selective IgA deficiency is more common in patients with celiac disease than in the general population, a total serum IgA level must be measured simultaneously. If the patient has an IgA deficiency, the IgA anti-tTG will be falsely negative, and IgG-based testing (such as IgG deamidated gliadin peptides) should be utilized instead.

Step-by-Step Solution

Analyze the clinical presentation.

The patient has chronic diarrhea, bloating, weight loss, and microcytic anemia.

Identifying the chronicity and specific characteristics of the symptoms helps narrow the differential diagnosis to malabsorptive disorders rather than acute infections.

Formulate a leading diagnosis.

Celiac disease is the most likely diagnosis.

The combination of foul-smelling stools (steatorrhea), significant weight loss, and iron deficiency anemia (indicated by low hemoglobin and low MCV) in a young adult strongly suggests celiac disease.

Select the appropriate initial laboratory investigation.

Ordering tissue transglutaminase IgA antibody and a total serum IgA level is indicated.

This is the standard, highly sensitive and specific first-line screening protocol for suspected celiac disease.

Key Concept

The initial laboratory evaluation for suspected celiac disease involves testing for tissue transglutaminase (tTG) IgA antibodies alongside a total serum IgA level to avoid false negatives in patients with concurrent selective IgA deficiency.

Question 4195Question →

A $31$ -year-old woman, gravida 2, para 1, at $9$ weeks gestation presents to the emergency department with a $2$ -day history of severe agitation, palpitations, vomiting, and diarrhea. She has a history of Graves disease, for which she stopped taking her medications when she discovered she was pregnant. She also has a history of severe persistent asthma requiring daily fluticasone and salmeterol inhalers, with her last exacerbation requiring endotracheal intubation three years ago.

On physical examination, her temperature is $39.4^\circ\text{C}$ ( $102.9^\circ\text{F}$ ), blood pressure is $152/68\text{ mmHg}$ , heart rate is $158/\text{min}$ and regular, and respiratory rate is $26/\text{min}$ . She is delirious, markedly tremulous, and diaphoretic. A diffusely enlarged, non-tender thyroid gland is palpable. Lung auscultation reveals diffuse bilateral end-expiratory wheezing.

Laboratory testing shows:
Thyroid-stimulating hormone (TSH): $<0.01\text{ \mu U/mL}$
Free thyroxine (T4): $5.4\text{ ng/dL}$ (Reference: $0.8-1.8\text{ ng/dL}$ )

An electrocardiogram shows sinus tachycardia.

Which of the following are appropriate initial pharmacologic interventions for this patient? (Select all that apply)

Select all that apply

Propylthiouracil

Intravenous hydrocortisone

Propranolol

Methimazole

High-dose aspirin

Show answer & explanation

Answer: Propylthiouracil; Intravenous hydrocortisone

Answer

The appropriate pharmacologic interventions are propylthiouracil and intravenous hydrocortisone.

The correct interventions are propylthiouracil (PTU) and intravenous hydrocortisone. The management of a thyroid storm requires halting thyroid hormone synthesis, blocking its release, blocking peripheral conversion of T4 to T3, and providing systemic supportive care. PTU is the preferred thioamide to halt synthesis during the first trimester of pregnancy due to the risk of methimazole-induced congenital malformations. Intravenous hydrocortisone is indicated to block the peripheral conversion of T4 to active T3, treat potential relative adrenal insufficiency, and modulate the underlying autoimmune process in Graves disease.

Step-by-Step Solution

Diagnose the primary condition based on clinical and laboratory findings.

The patient is experiencing a life-threatening thyroid storm, indicated by hyperpyrexia, severe tachycardia, delirium, gastrointestinal distress, and markedly elevated free T4 with suppressed TSH.

Recognizing the emergency dictates immediate, aggressive, and multifaceted pharmacologic intervention.

Identify relevant patient-specific comorbidities and physiologic states that restrict standard therapies.

The patient is in the first trimester of pregnancy and currently has an active exacerbation of severe asthma (diffuse wheezing, history of intubation).

Standard therapies for thyroid storm (methimazole, propranolol) may be absolutely contraindicated depending on the patient's underlying conditions.

Select the appropriate thioamide to block new thyroid hormone synthesis.

Propylthiouracil (PTU) is selected instead of methimazole.

Methimazole is associated with first-trimester teratogenicity (methimazole embryopathy, aplasia cutis). PTU is the drug of choice in the first trimester.

Select appropriate supportive therapies and alternative rate control.

Intravenous hydrocortisone is administered. Propranolol and aspirin are strictly avoided.

Hydrocortisone prevents peripheral T4 to T3 conversion and treats relative adrenal insufficiency. Propranolol (a non-selective beta-blocker) will precipitate fatal bronchospasm in a severe asthmatic. Aspirin displaces thyroid hormone from thyroid-binding globulin (TBG), exacerbating the thyrotoxic state. Acetaminophen should be used for fever, and a calcium channel blocker (like diltiazem) should be used for rate control.

Key Concept

The management of thyroid storm requires careful tailoring of pharmacotherapy to the patient's comorbidities: avoiding methimazole in the first trimester (teratogenic), avoiding non-selective beta-blockers in severe asthma (bronchospasm risk), and avoiding salicylates for fever control (displaces thyroid hormone from binding globulins).

Question 4196Question →

A $38$ -year-old woman is brought to the emergency department by her husband due to confusion and difficulty speaking that began earlier today. Her husband reports that for the past three days, she has complained of extreme fatigue, headaches, and a low-grade fever. She has not had any recent diarrhea, nausea, or abdominal pain. Her medical history is unremarkable, and she takes no prescription medications. Her temperature is $38.3^\circ\text{C}$ ( $100.9^\circ\text{F}$ ), pulse is $115$ /min, respirations are $18$ /min, and blood pressure is $142/88$ mmHg. Physical examination reveals scleral icterus and scattered petechiae over her bilateral lower extremities. She is disoriented to time and place, and her speech is intermittently slurred, though she moves all extremities with full strength.

Laboratory results:

Test	Result	Reference Range
Hemoglobin	$7.8$ g/dL	$12.0-16.0$ g/dL
Mean corpuscular volume	$88$ fL	$80-100$ fL
Platelets	$18,000/\text{mm}^3$	$150,000-400,000/\text{mm}^3$
Leukocytes	$8,400/\text{mm}^3$	$4,500-11,000/\text{mm}^3$
Blood urea nitrogen	$34$ mg/dL	$7-20$ mg/dL
Serum creatinine	$1.9$ mg/dL	$0.6-1.2$ mg/dL
Total bilirubin	$4.5$ mg/dL	$0.1-1.2$ mg/dL
Direct bilirubin	$0.8$ mg/dL	$0.0-0.3$ mg/dL
Lactate dehydrogenase	$1,450$ U/L	$100-250$ U/L
Prothrombin time	$12$ seconds	$11-14$ seconds
Partial thromboplastin time	$28$ seconds	$25-35$ seconds
Fibrinogen	$320$ mg/dL	$150-400$ mg/dL

A peripheral blood smear demonstrates numerous fragmented red blood cells. Which of the following is the most likely diagnosis?

Disseminated intravascular coagulation

Hemolytic uremic syndrome

Immune thrombocytopenic purpura

Thrombotic thrombocytopenic purpura

Evans syndrome

Show answer & explanation

Answer: Thrombotic thrombocytopenic purpura

Answer

Thrombotic thrombocytopenic purpura

The correct diagnosis is Thrombotic thrombocytopenic purpura (TTP). This patient presents with the classic pentad of TTP: microangiopathic hemolytic anemia (schistocytes, high LDH, anemia), severe thrombocytopenia, neurological symptoms (confusion, slurred speech), renal impairment (elevated BUN and creatinine), and fever. Importantly, the coagulation studies (PT, PTT, and fibrinogen) are perfectly normal, which confirms a primary thrombotic microangiopathy rather than a consumptive process like DIC. TTP is a medical emergency caused by severely decreased activity of the ADAMTS13 protease, leading to the accumulation of ultra-large von Willebrand factor multimers that shear red blood cells and consume platelets in the microvasculature.

Step-by-Step Solution

Analyze the patient's primary hematologic and laboratory abnormalities.

The patient has severe thrombocytopenia and microangiopathic hemolytic anemia (MAHA), evidenced by low hemoglobin, markedly elevated lactate dehydrogenase (LDH), indirect hyperbilirubinemia, and schistocytes on the peripheral blood smear.

Identifying the core pathophysiologic syndrome (MAHA with thrombocytopenia) narrows the differential diagnosis down to thrombotic microangiopathies (TMAs) and consumptive coagulopathies.

Evaluate the coagulation profile to differentiate between primary TMAs and consumptive coagulopathies.

Prothrombin time (PT), partial thromboplastin time (PTT), and fibrinogen levels are all within normal limits.

A normal coagulation profile rules out Disseminated Intravascular Coagulation (DIC), which characteristically presents with prolonged PT/PTT and low fibrinogen due to the systemic consumption of clotting factors.

Differentiate among the primary TMAs based on the clinical presentation and extent of organ involvement.

The patient exhibits prominent neurological symptoms (confusion, aphasia), fever, and mild renal impairment, without any preceding diarrheal illness.

The presence of the classic pentad (fever, neurologic changes, renal failure, MAHA, and thrombocytopenia) strongly indicates Thrombotic Thrombocytopenic Purpura (TTP), distinguishing it from Hemolytic Uremic Syndrome (HUS), which typically features a bloody diarrheal prodrome and more severe acute kidney injury.

Key Concept

Formulating a differential diagnosis for microangiopathic hemolytic anemia (MAHA) and thrombocytopenia using coagulation profiles and clinical presentation.

Question 4197Question →

A 41-year-old woman is evaluated in the rheumatology clinic for a follow-up visit. Two weeks ago, she was diagnosed with highly active, seropositive rheumatoid arthritis after presenting with persistent symmetric polyarthritis of her wrists, metacarpophalangeal, and proximal interphalangeal joints. She has no other medical conditions and takes no medications other than ibuprofen as needed. Physical examination shows active synovitis in both hands. Recent laboratory studies from her initial diagnostic workup demonstrate a normal complete blood count, normal comprehensive metabolic panel, positive rheumatoid factor, and positive anti-cyclic citrullinated peptide antibodies. After a discussion of treatment goals, the physician and patient agree to initiate systemic therapy with once-weekly oral methotrexate and daily folic acid supplementation. Which of the following additional tests must be obtained to establish safety baselines and rule out absolute contraindications prior to initiating this specific pharmacotherapy? (Select 2)

Select all that apply

Urine human chorionic gonadotropin level

Hepatitis B and C serologic panel

Thiopurine methyltransferase (TPMT) phenotype testing

Transthoracic echocardiography

Prothrombin time and international normalized ratio

Show answer & explanation

Answer: Urine human chorionic gonadotropin level; Hepatitis B and C serologic panel

Answer

The necessary baseline tests prior to initiating methotrexate in this patient include a urine human chorionic gonadotropin level and a Hepatitis B and C serologic panel.

Methotrexate is an immunosuppressive folate antimetabolite with a specific toxicity profile requiring rigorous baseline evaluation. It is highly teratogenic (an abortifacient) and is absolutely contraindicated in pregnancy; therefore, a human chorionic gonadotropin (hCG) level must be obtained in all women of childbearing potential before initiation. Furthermore, methotrexate carries a high risk of cumulative hepatotoxicity and can cause severe or fatal reactivation of chronic viral hepatitis. Because of this immunosuppressive risk, baseline screening with a Hepatitis B and C serologic panel is universally mandatory according to current rheumatology guidelines.

Step-by-Step Solution

Analyze the clinical scenario and proposed pharmacotherapy.

The patient is a 41-year-old female of childbearing potential who will be started on methotrexate for newly diagnosed rheumatoid arthritis.

Identifying patient demographics and the specific drug helps determine the required baseline safety monitoring protocols.

Evaluate the specific toxicity profile of the chosen medication.

Methotrexate is a folate antimetabolite known for severe teratogenicity, hepatotoxicity, pulmonary toxicity, and myelosuppression.

Understanding the adverse effect profile dictates which organ systems and contraindications require baseline laboratory evaluation.

Select the appropriate screening tests from the provided choices based on the established safety requirements.

A pregnancy test (hCG) is required due to teratogenicity, and a hepatitis panel is required to prevent reactivation of latent liver disease. TPMT, echocardiography, and PT/INR are not indicated for methotrexate.

Ensuring patient safety requires matching the baseline diagnostic workup directly to the known risks of the immunosuppressive agent.

Key Concept

Baseline safety monitoring for methotrexate therapy requires evaluating for pregnancy (in women of childbearing potential), chronic viral hepatitis, baseline cytopenias, and renal impairment.

Estimated Time:1m 30s

Question 4198Question →

A quality improvement task force at a regional medical center is designing a prospective trial to evaluate the effectiveness of a new automated sepsis alert system. The primary outcome is the time from triage to the administration of broad-spectrum antibiotics, measured as a continuous variable in minutes.

The investigators conduct a preliminary power analysis and find that their proposed study design achieves a statistical power of only $0.55$ for detecting a $15$ -minute difference in administration times between the new and standard alert systems. The principal investigator requests modifications to the study design or analysis plan to achieve a target power of $0.80$ before initiating the trial.

Which of the following proposals will appropriately increase the statistical power of this trial? (Select all that apply)

Select all that apply

Extending the planned data collection period from

6

months to

12

months to increase the total number of patient encounters analyzed

Standardizing the electronic time-tracking methodology across all clinical departments to decrease the variance in the reported administration times

Converting the continuous primary outcome into a categorical variable (e.g.,

<60

minutes vs

\geq 60

minutes) and analyzing it using a chi-square test

Stratifying the primary analysis into multiple small age-based subgroups to account for potential effect modification

Pausing the study to perform a root cause analysis (RCA) to prospectively identify and eliminate potential protocol failure modes

Show answer & explanation

Answer: Extending the planned data collection period from $6$ months to $12$ months to increase the total number of patient encounters analyzed; Standardizing the electronic time-tracking methodology across all clinical departments to decrease the variance in the reported administration times

Answer

Extending the planned data collection period and standardizing the electronic time-tracking methodology will both appropriately increase the statistical power of the trial.

Statistical power (

1 - \beta

) is primarily driven by four factors: sample size, variance, effect size, and the chosen significance level (

\alpha

). Extending the data collection period increases the total sample size (

n

). Standardizing the tracking methodology decreases the measurement variance (

\sigma^2

). Because power increases as sample size grows and as variance shrinks, both of these methodological changes will successfully increase the statistical power of the trial.

Step-by-Step Solution

Identify the current methodological problem.

The study is underpowered at

0.55

, meaning there is a

45\%

chance of committing a Type II error (failing to detect a true difference).

Recognizing the risk of Type II error establishes the need to optimize the mathematical parameters that govern statistical power.

Recall the variables that determine statistical power.

Statistical power (

1 - \beta

) is increased by: higher sample size (

n

), larger effect size, higher significance level (

\alpha

), and smaller variance (

\sigma^2

These are the core components of the power equation for continuous outcomes.

Evaluate the proposed modifications against the determinants of power.

Extending data collection increases

n

. Standardizing tracking decreases

\sigma^2

. Both mathematically increase power. Categorizing data, stratifying into smaller groups, or performing an RCA do not increase power.

Only modifications that favorably alter the mathematical determinants of power will solve the investigator's problem.

Key Concept

Statistical power is the probability of correctly rejecting the null hypothesis when a true difference exists. Power is directly increased by increasing the sample size (

n

), increasing the expected effect size, accepting a higher Type I error rate (

\alpha

), or decreasing the variance (

\sigma^2

) of the outcome measure.

Question 4199Question →

A group of neurologists at a large regional healthcare network is investigating the association between long-term use of a specific calcitonin gene-related peptide (CGRP) antagonist and the incidence of new-onset hypertension. They query the network's electronic health record (EHR) database to identify all adult patients diagnosed with chronic migraine between 2018 and 2021. Patients are stratified into two groups: those who were prescribed the CGRP antagonist for at least 12 months, and those who were treated solely with other prophylactic medications. The researchers then analyze the EHR data longitudinally through 2025 to determine the proportion of patients in each group who subsequently received a new diagnosis of hypertension. Which of the following statements accurately describe the methodological characteristics of this study design? (Select all that apply)

Select all that apply

It allows for the direct calculation of incidence rates and relative risk.

The use of pre-existing medical records minimizes the risk of recall bias regarding medication exposure.

It provides better protection against confounding by indication compared to a randomized controlled trial.

The primary measure of association for this design must be the odds ratio because absolute incidence cannot be determined.

The participant selection process initially groups individuals based on the presence or absence of the primary outcome.

Show answer & explanation

Answer: It allows for the direct calculation of incidence rates and relative risk.; The use of pre-existing medical records minimizes the risk of recall bias regarding medication exposure.

Answer

The correct statements are that the study allows for the direct calculation of incidence rates and relative risk, and that using pre-existing medical records minimizes recall bias.

The clinical scenario describes a retrospective cohort study. The researchers identified a cohort of patients based on their past exposure to a specific medication (the CGRP antagonist) and tracked their electronic health records forward in time to measure the development of a new outcome (hypertension). Because cohort studies track initially disease-free individuals over a defined risk period, they allow for the direct measurement of incidence and the calculation of relative risk (risk ratios). Furthermore, by utilizing objective, pre-existing electronic health records to determine exposure status, this design fundamentally avoids the recall bias that frequently limits studies relying on patient interviews or questionnaires.

Step-by-Step Solution

Identify the study design described in the vignette.

The design is a retrospective cohort study.

Participants are identified based on past exposure status (CGRP antagonist vs. other medications) and followed forward in historical time to assess for the development of a subsequent outcome (hypertension).

Evaluate the statistical measures applicable to a retrospective cohort design.

Incidence rates and relative risk can be directly calculated.

Cohort studies track initially disease-free populations over time, allowing for the observation of new cases (incidence) and the direct comparison of risk between exposed and unexposed groups.

Evaluate the specific biases associated with the described data collection method.

Recall bias is minimized.

Exposure status is determined via objective, pre-existing electronic health records rather than relying on patient memory, thereby eliminating differential recall between the groups.

Key Concept

Retrospective Cohort Study Methodology and Bias Recognition

Question 4200Question →

A clinical research group analyzes an electronic health record database to evaluate a potential link between a newly approved GLP-1 receptor agonist and the incidence of acute pancreatitis in adults with type 2 diabetes mellitus. The initial unadjusted analysis yields a relative risk (RR) of $2.1$ ( $95\%$ Confidence Interval [CI]: $1.5 - 2.8$ ), suggesting a statistically significant increase in risk. Suspecting an underlying methodological phenomenon, the researchers re-analyze the data by stratifying the patient population according to a history of severe hypertriglyceridemia. In the stratum of patients with a history of severe hypertriglyceridemia, the RR is $1.1$ ( $95\%$ CI: $0.7 - 1.6$ ). In the stratum of patients with normal triglyceride levels, the RR is $1.0$ ( $95\%$ CI: $0.8 - 1.3$ ). Which of the following concepts best explains why the initial unadjusted relative risk was significantly elevated?

The unadjusted analysis failed to account for a variable associated with both the medication use and the outcome.

The medication exerts a different magnitude of biological effect depending on the patient's baseline lipid status.

The evaluating clinicians had preconceived expectations about the medication, leading to diagnostic distortion.

The probability of a true positive diagnosis was artificially altered by the disease prevalence in the sample.

The researchers utilized an inappropriate inferential statistical test to compare the categorical incidence rates.

Show answer & explanation

Answer: The unadjusted analysis failed to account for a variable associated with both the medication use and the outcome.

Answer

The unadjusted analysis failed to account for a variable associated with both the medication use and the outcome.

The correct answer accurately describes the mechanism of a confounding variable. Confounding occurs when a third variable is associated with both the exposure (GLP-1 agonist use) and the outcome (acute pancreatitis), but is not on the causal pathway. In this scenario, patients with severe hypertriglyceridemia may be more likely to be prescribed a GLP-1 agonist and are independently at a higher risk for acute pancreatitis. In the crude analysis, this makes it appear as though the medication causes pancreatitis. However, when the researchers control for this third variable via stratification, the relative risk drops to approximately 1.0 in both strata. The disappearance of the association upon stratification is the classic hallmark of confounding.

Step-by-Step Solution

Analyze the unadjusted study results.

The initial crude relative risk is 2.1, indicating a statistically significant association between the GLP-1 receptor agonist and acute pancreatitis.

Establishing the baseline finding is necessary to understand how subsequent analysis changes the interpretation.

Evaluate the results of the stratified analysis.

When stratified by a history of severe hypertriglyceridemia, the relative risk in both the high-triglyceride group (

RR = 1.1

) and normal-triglyceride group (

RR = 1.0

) becomes non-significant and close to the null value of 1.0.

Stratification is the primary method used to distinguish between confounding and effect modification.

Determine the epidemiological concept driving the change.

Because the significant association completely disappears when the data is divided into strata based on a third variable, that third variable (hypertriglyceridemia) is a confounder.

A confounder creates a spurious association in crude data because it is independently linked to both the exposure and the outcome.

Key Concept

Confounding is present when a third variable is associated with both the exposure and the outcome, creating a false association in unadjusted data that disappears upon stratification.

Estimated Time:1m 15s

PreviousPage 210 / 237Next

All practice questions

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept